Gene: ATP2C2
Official Full Name: ATPase secretory pathway Ca2+ transporting 2provided by HGNC
Gene Summary: Enables P-type calcium transporter activity and P-type manganese transporter activity. Predicted to be involved in calcium ion transmembrane transport; intracellular calcium ion homeostasis; and manganese ion transport. Predicted to act upstream of or within mammary gland epithelium development; positive regulation of calcium ion import; and protein localization to plasma membrane. Predicted to be located in trans-Golgi network membrane. Predicted to be active in Golgi membrane; endoplasmic reticulum; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32526 | ATP2C2 Knockout cell line (HCT 116) | Human | ATP2C2 | 1:2~1:4 | Negative | Online Inquiry |
ATP2C2 Gene Knockout Cell Lines are specialized cellular systems engineered to lack the ATP2C2 gene, which encodes a calcium-transporting ATPase involved in maintaining intracellular calcium homeostasis. These knockout cell lines provide researchers with a valuable tool for investigating the multifaceted roles of calcium signaling in cellular processes, including growth, differentiation, and apoptosis. By eliminating ATP2C2, scientists can gain insights into the gene’s contribution to calcium pathways and how disruptions may lead to pathological conditions.
The key function of ATP2C2 in cellular contexts revolves around its ability to actively transport calcium ions from the cytosol into the endoplasmic reticulum (ER), thereby regulating calcium levels crucial for various cellular functions. In knockout models, the disruption of this transport mechanism can elucidate alternative calcium regulation pathways and their implications in health and disease. For instance, researchers studying neurodegenerative diseases or cancer can better understand how calcium dysregulation contributes to disease mechanisms, potentially leading to novel therapeutic targets.
Scientific applications of ATP2C2 Gene Knockout Cell Lines extend beyond basic research. They can be leveraged in drug development, toxicity testing, and investigations into calcium's involvement in pathophysiological processes. The precise alteration of calcium signaling makes these cell lines a unique model for studying calcium-associated disorders, providing a clearer picture of cellular responses under varying conditions.
Unlike traditional cell lines, the ATP2C2 knockout models offer the specific advantage of targeted gene deletion, allowing for more definitive conclusions about gene function. This is crucial for obtaining reproducible results that are often hindered in less precise systems. Furthermore, these cell lines are validated and characterized, ensuring reliability in experimental outcomes.
For researchers and clinicians, the ATP2C2 Gene Knockout Cell Lines represent a significant advancement. They provide clarity on calcium dynamics and their potential implications in disease mechanisms, equipping scientists with critical insights necessary for developing innovative therapies. Our company prides itself on its unwavering commitment to high-quality biological research tools supported by extensive expertise in genetic models, enabling investigators to push the boundaries of scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.